MAPT and Alzheimer disease: These authors suggested that AMPK activation at an early stage (i.e., presymptomatic two-month-old SAMP8 mice) without prominent AD pathologies plays a protective role against detrimental stress in the cerebral cortex, as the activation of cortical AMPK inhibits the GSK3β-mediated hyperphosphorylation of tau.